TY  - JOUR

T1  - Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

JO  - Journal of Clinical Oncology

PY  - 2002/07/15

AU  - Biganzoli L

AU  - Cufer T

AU  - Bruning P

AU  - Coleman R

AU  - Duchateau L

AU  - Calvert AH

AU  - Gamucci T

AU  - Twelves C

AU  - Fargeot P

AU  - Epelbaum R

AU  - Lohrisch C et al

ED  - 

DO  - DOI: 10.1200/jco.2002.11.005

PB  - American Society of Clinical Oncology (ASCO)

VL  - 20

IS  - 14

SP  - 3114

EP  - 3121

Y2  - 2025/10/10

ER  -